Mira: Revolutionizing Fertility Tracking and Hormone Health During Perimenopause and Menopause

Tracking fertility and hormone health has long been a challenge for many women, especially during the complex phases of perimenopause and menopause. Traditional methods often fall short in providing clear, personalized insights. Mira offers a new approach, combining advanced hormone tracking technology with user-friendly design to support women throughout their fertility journey and beyond.

Mira is an at-home hormone tracking system designed to measure key fertility hormones through urine testing. Unlike traditional ovulation predictor kits (OPKs) that detect only luteinizing hormone (LH), Mira measures multiple hormones, including Luteinizing hormone (LH), Estrone-3-glucuronide (E3G), a metabolite of estrogen, Pregnanediol glucuronide (PdG), a metabolite of progesterone, and Follicle Stimulating Hormone (FSH). By tracking these hormones daily, Mira provides a comprehensive hormonal profile that helps users understand their fertility window, ovulation patterns, and hormone fluctuations. Mira helps identify subtle cycle irregularities that might otherwise go unnoticed, making it a tremendous ally for those with PCOS, or those trying to conceive, as well as women going through perimenopause or menopause. Mira can offer insight into the hormone cycling of women with hysterectomy as well, thus providing the ability for practitioners to offer precise symptom support and relief.

The device connects to a smartphone app, which analyzes hormone levels and presents clear, personalized insights. This allows users to make informed decisions about conception, contraception, or hormone health management. Additionally, the app can be linked to your provider's dashboard, allowing for up-to-the-moment support when it is needed. Mira’s multi-hormone tracking offers several advantages for women trying to conceive. Mira detects the rise in estrogen and the LH surge, pinpointing the fertile window more precisely than single-hormone tests. It measures PdG after ovulation confirms that ovulation has occurred, which many OPKs cannot do, and tracks hormones over multiple cycles helps identify irregularities such as luteal phase defects or anovulatory cycles. Research highlights that users who track multiple hormones with Mira have a better understanding of their cycles and improved timing for intercourse, which can increase pregnancy rates.

Hormone fluctuations during perimenopause and menopause can cause symptoms like irregular periods, hot flashes, mood changes, and sleep disturbances. Monitoring hormone levels can help women and healthcare providers manage these changes more effectively. Mira’s ability to measure estrogen and progesterone metabolites provides insight into the hormonal shifts typical of perimenopause. By correlating hormone levels with symptoms, women can better understand their bodies and discuss targeted treatments with their doctors. For women on certain deliveries of hormone replacement therapy (HRT), Mira can help track hormone levels to optimize dosage and timing. Having daily hormone data allows women to take an active role in managing their health during this transitional phase.

While research specifically on Mira’s use in menopause is emerging, the principles of hormone monitoring are well-established in clinical practice. Mira’s accessible technology brings this capability into the home, making hormone health management more convenient. Many at-home fertility tests focus on detecting a single hormone, usually LH, to predict ovulation. Research suggests that tracking multiple hormones improves ovulation prediction accuracy compared to LH-only tests. Some newer devices measure additional hormones but often lack the precision or ease of use Mira offers. Mira measures LH, E3G, PdG, and FSH, providing a fuller picture of the menstrual cycle compared to tests that only detect LH.

One of the many reasons Mira's technology is useful is because it prioritizes FSH. Emerging research finds that FSH could be a predictor of health outcomes due to its high number of receptors through the body, as well as its ability to operate independent of estrogen. During perimenopause, FSH levels rise as ovarian function declines, signaling the transition to menopause. However, FSH fluctuates from cycle to cycle, so a single measurement may not reflect the progression. Elevated FSH often coincides with decreased estrogen and irregular cycles. FSH, along with E3G, can provide insights but should be interpreted cautiously due to natural fluctuations.

Instead of a simple positive/negative result, Mira provides hormone concentration levels, allowing for trend analysis. The app offers personalized cycle tracking, reminders, and data visualization, which many competitors lack. Studies show strong correlation between Mira’s hormone measurements and laboratory assays, supporting its reliability. In fact, a study comparing Mira’s hormone measurements to laboratory immunoassays found high correlation, confirming its precision. Mira’s digital reader is reusable with disposable test wands, making it cost-effective over time compared to single-use kits.

Tracking hormones at home has never been this accessible or informative. Mira’s technology bridges the gap between clinical hormone testing and everyday health management. Whether you are trying to conceive, addressing PCOS, navigating perimenopause, or managing menopause symptoms, Mira offers a reliable tool to support your journey and empowers women with clear, actionable hormone data, helping them understand their bodies better and make informed decisions about fertility and hormone health. Consider integrating Mira into your routine to gain deeper insights and take control of your hormone health. If you are interested in learning more about Mira, and how to better manage hormone health, check out Soul Minded Integrative Health or schedule a FREE Discovery Call.

FREE Discovery Call

Learn More about Mira